[医药制造业] [2024-03-06]
全球医疗健康融资额2023年同比2022年仍有一定幅度下滑,基本接近2019年水平。2023年全球生物医药融资金额为575.43亿美元,同比2022年下滑34%,与2019年融资额631.05亿美元基本接近。2023Q4融资金额小幅仍然下滑,2023Q1-2023Q3三个季度融资金额环比保持平稳。2022Q4-2023Q3 全球医疗健康季度融资金额分别为155.52、152.45、154.58、152.03亿美元,季度间环比保持平稳。2023Q4季度融资金额为116.38亿美元,同比2022Q4季度融资金额下滑25%。
[科学研究和技术服务业,医药制造业] [2024-03-04]
[医药制造业] [2024-02-29]
[医药制造业] [2024-02-29]
Meal replacement products are calorie-controlled, pre-packaged products such as bars and beverages, which can be consumed instead of a heavy meal. Meal replacement products have many nutritional benefits. Moreover, they are affordable and convenient. Initially, meal replacement products were used by the elderly population, but now they are being marketed to adults. Major brands are also carrying out several marketing activities to create more awareness about meal replacement products.
[食品制造业,医药制造业,农副食品加工业] [2024-02-29]
Functional chewing gum imparts several health benefits upon consumption, unlike traditional chewing gum, which is mainly consumed as a confectionary product. The several health benefits of functional chewing gum make it highly demanded among consumers across the world.
[医药制造业] [2024-02-29]
Ewing's sarcoma is a cancerous tumor that arises in the bone or soft tissue. There are different types of Ewing's sarcoma; the most common type is Ewing's sarcoma of bone. Monotherapy and combination therapy are used to treat Ewing's sarcoma. Currently, monotherapy involves treatment with chemotherapeutics, whereas combination therapy involves treatment with chemotherapeutics in combination with radiation therapy.
[医药制造业] [2024-02-29]
The global ED drugs market consists of drugs indicated for the treatment of ED. These drugs include oral, topical, and other formulations, available both as prescription drugs and over-the-counter (OTC) drugs. Oral drugs were the first class of drugs that were developed for the treatment of ED. They hold a major share of the market because of their relative ease of administration. Topical drugs, sublingual, injectables, and suppositories, which have recently entered the market, hold small market shares.
[仪器仪表制造业,计算机、通信和其他电子设备制造业,医药制造业] [2024-02-29]
The term dermatology laser is used to describe a type of high-energy laser designed for medical procedures within the dermatology field. Dermatological lasers use a particular wavelength of light to precisely target and penetrate a particular layer of the skin. This allows for the precise treatment of a variety of skin conditions, such as improved skin appearance, the treatment of skin diseases, the removal of unwanted hair, the removal of tattoos, the reduction of wrinkles, scars, and other skin blemishes. The use of a particular type of laser depends on the intended treatment and the target area of the body.
[医药制造业] [2024-02-27]
2023 年,国家药品监督管理局(NMPA)共批准了 85 款新药(新药统计范围为首次在国内获批的 1 类、3.1 类、5.1 类化学药品和生物制品),其中包括 62 款化学药品(占比 72.9%)以及 23 款生物制品(占比 27.1%)。与往年相比,2023 年 NMPA 批准新药数量显著上涨,为近 6 年最高。2023 年国产新药获批 29 款,相比 2022 年显著增长。
[医药制造业] [2024-02-27]
2024 年 ASCO GI 和 ASCO GU 会议召开,多项成果引人注目 ASCO GI 和 ASCO GU 分别于 1 月 18 日和 1 月 25 日开幕。海外创新药中,enfortumab vedotin(EV)一线治疗 UC 表现出色,NiPi 组合再创佳绩,tiragolumab 治疗 ESCC 的 III 期研究结果积极。两大会议上有近 70 项 国产创新药的临床成果入选(不计入仅披露临床设计的项目),其中维迪西妥单抗、CT041、戈来雷塞、ASKB589 等的早期临床数据靓丽。我们继续看好国产创新药前景,基于:1)国产 ADC 数据惊艳,彰显其成为成为肿瘤治疗新基石疗法的潜力与国内药企在该领域的全球市场竞争力;2)多项国产创新药披露优秀美国临床数据,国内药企出海能力持续提升;3)国产创新药在胰腺癌等未满足需求大但满足度低的领域中带来新的突破希望。